Effect of bupivacaine on sevoflurane-induced preconditioning in isolated rat hearts

European Journal of Pharmacology

Volumn 647, Issue 1-3, 2010, Pages 132-138

  Bouwman, R Arthur ^a   Vreden, M Jumoke A ^a   Hamdani, Nazha ^b   Wassenaar, Lisan E J ^a   Smeding, Lonneke ^a   Loer, Stephan A ^a   Stienen, Ger J M ^b   Lamberts, Regis R ^b,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cardiac function; Ischemia reperfusion; Local anesthetics; Preconditioning; Signal transduction; Volatile anesthetics

Indexed keywords

BUPIVACAINE; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; SEVOFLURANE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANESTHETICS, INHALATION; ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; HEART; HEART DISEASES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; METHYL ETHERS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; PHOSPHORYLATION; PROTECTIVE AGENTS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; VENTRICULAR FUNCTION, LEFT;

EID: 77957307360     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.08.014     Document Type: Article

References (38)

1. Barthel H., Ebel D., Müllenheim J., Obal D., Preckel B., Schlack W. Effect of lidocaine on ischaemic preconditioning in isolated rat heart. Br. J. Anaesth. 2004, 93:698-704.
2. Beal J.L., Freysz M., Timour Q., Bertrix L., Lang J., Faucon G. Haemodynamic effects of high plasma concentrations of bupivacaine in the dog. Eur. J. Anaesthesiol. 1988, 5:251-260.
3. Bouwman R.A., Musters R.J., van Beek-Harmsen B.J., De Lange J., Boer C. Reactive oxygen species precede protein kinase C-delta activation independent of adenosine triphosphate-sensitive mitochondrial channel opening in sevoflurane-induced cardioprotection. Anesthesiology 2004, 100:506-514.
4. Bouwman R., Musters R., Van Beek-Harmsen B., De Lange J., Lamberts R., Loer S., Boer C. Sevoflurane-induced cardioprotection depends on PKC- activation via production of reactive oxygen species. Br. J. Anaesth. 2007, 99:639-645.
5. Bozkurt P., Suzer O., Ekici E., Demirci O., Kaya G., Hacibekiroglu M. Effects of bupivacaine used with sevoflurane on the rhythm and contractility in the isolated rat heart. Eur. J. Anaesthesiol. 2003, 20:199-204.
6. Clarkson C.W., Hondeghem L.M. Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology 1985, 62:396-405.
7. Cuvillon P., Nouvellon E., Ripart J., Boyer J., Dehour L., Mahamat A., L'hermite J., Boisson C., Vialles N., Lefrant J., De La Coussaye J. A comparison of the pharmacodynamics and pharmacokinetics of bupivacaine, ropivacaine (with epinephrine) and their equal volume mixtures with lidocaine used for femoral and sciatic nerve blocks: a double-blind randomized study. Anesth. Analg. 2009, 108:641-649.
8. De Hert S., Ten Broecke P., Mertens E., Van Sommeren E.W., De Blier I.G., Stockman B., Rodrigus I. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002, 97:42-49.
9. De Klaver M., Weingart G., Obrig T., Rich G. Local anesthetic-induced protection against lipopolysaccharide-induced injury in endothelial cells: the role of mitochondrial adenosine triphosphate-sensitive potassium channels. Anesth. Analg. 2006, 102:1108-1113.
10. de Leeuw M.A., Bet P.M., Wilhelm A.J., Vos R.M., Hoeksema M., de Lange J.J., Zuurmond W.W., Perez R.S. Total plasma concentrations of bupivacaine, levobupivacaine and ropivacaine after combined psoas compartment-sciatic nerve block. Eur. J. Anaesthesiol. 2009, 26:1083-1085.
11. Ebel D., Preckel B., You A., Mullenheim J., Schlack W., Thamer V. Cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat is independent of three types of cardioplegia. Br. J. Anaesth. 2002, 88:828-835.
12. Feng J., Lucchinetti E., Ahuja P., Pasch T., Perriard J.C., Zaugg M. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta. Anesthesiology 2005, 103:987-995.
13. Ferrera R., Benhabbouche S., Bopassa J.C., Li B., Ovize M. One hour reperfusion is enough to assess function and infarct size with TTC staining in Langendorff rat model. Cardiovasc. Drugs Ther. 2009, 23:327-331.
14. Freysz M., Timour Q., Bertrix L., Loufoua-Moundanga J., Omar S., Faucon G. Enhancement by ischemia of the risk of cardiac disorders, especially fibrillation, in regional anesthesia with bupivacaine. Acta Anaesthesiol. Scand. 1993, 37:350-356.
15. Freysz M., Timour Q., Bertrix L., Loufoua J., Aupetit J.F., Faucon G. Bupivacaine hastens the ischemia-induced decrease of the electrical ventricular fibrillation threshold. Anesth. Analg. 1995, 80:657-663.
16. Fryer R.M., Hsu A.K., Eells J.T., Nagase H., Gross G.J. Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels. Circ. Res. 1999, 84:846-851.
17. Haigney M.C., Lakatta E.G., Stern M.D., Silverman H.S. Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading. Circulation 1994, 90:391-399.
18. Kaczmarek D.J., Herzog C., Larmann J., Gillmann H.J., Hildebrand R., Schmitz M., Westermann A., Harendza T., Werdehausen R., Osthaus A.W., Echtermeyer F., Hahnenkamp K., Wollert K.C., Theilmeier G. Lidocaine protects from myocardial damage due to ischemia and reperfusion in mice by its antiapoptotic effects. Anesthesiology 2009, 110:1041-1049.
19. Kharasch E.D., Karol M.D., Lanni C., Sawchuk R. Clinical sevoflurane metabolism and disposition. I. Sevoflurane and metabolite pharmacokinetics. Anesthesiology 1995, 82:1369-1378.
20. Kim S., Kudej R., Yatani A., Kim Y., Takagi G., Honda R., Colantonio D., Van Eyk J., Vatner D., Rasmusson R., Vatner S. A Novel Mechanism for Myocardial Stunning Involving Impaired Ca2+ Handling. Circ. Res. 2001, 89:831-837.
21. Knudsen K., Beckman Suurküla M., Blomberg S., Sjövall J., Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br. J. Anaesth. 1997, 78:507-514.
22. Lamberts R., Vaessen R., Westerhof N., Stienen G. Right ventricular hypertrophy causes impairment of left ventricular diastolic function in the rat. Basic Res. Cardiol. 2007, 102:19-27.
23. Lamberts R.R., Onderwater G., Hamdani N., Vreden M.J.A., Steenhuisen J., Eringa E.C., Loer S.A., Stienen G.J.M., Bouwman R.A. Reactive Oxygen Species-Induced Stimulation of 5'AMP-Activated Protein Kinase Mediates Sevoflurane-Induced Cardioprotection. Circulation 2009, 120:S10-S15.
24. Lange M., Redel A., Smul T.M., Lotz C., Nefzger T., Stumpner J., Blomeyer C., Gao F., Roewer N., Kehl F. Desflurane-induced preconditioning has a threshold that is lowered by repetitive application and is mediated by beta(2)-adrenergic receptors. J. Cardiothorac. Vasc. Anesth. 2009, 23:607-613.
25. Ludwig L., Patel H.H., Gross G.J., Kersten J., Pagel P., Warltier D. Morphine enhances pharmacological preconditioning by isoflurane: role of mitochondrial K(ATP) channels and opioid receptors. Anesthesiology 2003, 98:705-711.
26. Novalija E., Kevin L., Camara A.K., Bosnjak Z., Kampine J.P., Stowe D. Reactive oxygen species precede the epsilon isoform of protein kinase C in the anesthetic preconditioning signaling cascade. Anesthesiology 2003, 99:421-428.
27. Raphael J. Isoflurane-induced myocardial preconditioning is dependent on phosphatidylinositol-3-kinase/Akt signalling. Br. J. Anaesth. 2005, 95:756-763.
28. Ross J.D., Ripper R., Law W.R., Massad M., Murphy P., Edelman L., Conlon B., Feinstein D.L., Palmer J.W., DiGregorio G., Weinberg G.L. Adding bupivacaine to high-potassium cardioplegia improves function and reduces cellular damage of rat isolated hearts after prolonged, cold storage. Anesthesiology 2006, 105:746-752.
29. Schlack W., Preckel B., Stunneck D., Thamer V. Effects of halothane, enflurane, isoflurane, sevoflurane and desflurane on myocardial reperfusion injury in the isolated rat heart. Br. J. Anaesth. 1998, 81:913-919.
30. Sztark F., Malgat M., Dabadie P., Mazat J.P. Comparison of the effects of bupivacaine and ropivacaine on heart cell mitochondrial bioenergetics. Anesthesiology 1998, 88:1340-1349.
31. Tanz R.D., Heskett T., Loehning R.W., Fairfax C.A. Comparative cardiotoxicity of bupivacaine and lidocaine in the isolated perfused mammalian heart. Anesth. Analg. 1984, 63:549-556.
32. Toller W.G., Kersten J.R., Pagel P.S., Hettrick D.A., Warltier D.C. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Anesthesiology 1999, 91:1437-1446.
33. Toma O., Weber N.C., Wolter J.I., Obal D., Preckel B., Schlack W. Desflurane preconditioning induces time-dependent activation of protein kinase C epsilon and extracellular signal-regulated kinase 1 and 2 in the rat heart in vivo. Anesthesiology 2004, 101:1372-1380.
34. Varadarajan S.G., An J., Novalija E., Stowe D. Sevoflurane before or after ischemia improves contractile and metabolic function while reducing myoplasmic Ca(2+) loading in intact hearts. Anesthesiology 2002, 96:125-133.
35. Weinberg G.L., Palmer J.W., VadeBoncouer T.R., Zuechner M.B., Edelman G., Hoppel C.L. Bupivacaine inhibits acylcarnitine exchange in cardiac mitochondria. Anesthesiology 2000, 92:523-528.
36. Weinberg G., Paisanthasan C., Feinstein D., Hoffman W. The effect of bupivacaine on myocardial tissue hypoxia and acidosis during ventricular fibrillation. Anesth. Analg. 2004, 98:790-795 table of contents.
37. Yan M., Chen C., Zhang F., Chen G. Lidocaine abolishes the myocardial protective effect of sevoflurane post-conditioning. Acta Anaesthesiol. Scand. 2008, 52:111-116.
38. Zaugg M. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br. J. Anaesth. 2003, 91:551-565.